QQQ   296.14 (-3.28%)
AAPL   143.54 (-3.82%)
MSFT   257.25 (-3.59%)
FB   196.07 (-3.23%)
GOOGL   2,263.13 (-2.85%)
AMZN   2,183.86 (-5.35%)
TSLA   731.31 (-3.98%)
NVDA   173.93 (-4.31%)
BABA   89.37 (-2.85%)
NIO   16.25 (-2.29%)
AMD   98.77 (-3.61%)
CGC   5.77 (-2.04%)
MU   72.02 (-3.30%)
T   20.46 (-0.53%)
GE   75.65 (-0.98%)
F   13.02 (-3.77%)
DIS   105.81 (-2.60%)
AMC   13.47 (+4.42%)
PFE   50.58 (-1.48%)
PYPL   78.10 (-2.07%)
NFLX   182.77 (-4.09%)
QQQ   296.14 (-3.28%)
AAPL   143.54 (-3.82%)
MSFT   257.25 (-3.59%)
FB   196.07 (-3.23%)
GOOGL   2,263.13 (-2.85%)
AMZN   2,183.86 (-5.35%)
TSLA   731.31 (-3.98%)
NVDA   173.93 (-4.31%)
BABA   89.37 (-2.85%)
NIO   16.25 (-2.29%)
AMD   98.77 (-3.61%)
CGC   5.77 (-2.04%)
MU   72.02 (-3.30%)
T   20.46 (-0.53%)
GE   75.65 (-0.98%)
F   13.02 (-3.77%)
DIS   105.81 (-2.60%)
AMC   13.47 (+4.42%)
PFE   50.58 (-1.48%)
PYPL   78.10 (-2.07%)
NFLX   182.77 (-4.09%)
QQQ   296.14 (-3.28%)
AAPL   143.54 (-3.82%)
MSFT   257.25 (-3.59%)
FB   196.07 (-3.23%)
GOOGL   2,263.13 (-2.85%)
AMZN   2,183.86 (-5.35%)
TSLA   731.31 (-3.98%)
NVDA   173.93 (-4.31%)
BABA   89.37 (-2.85%)
NIO   16.25 (-2.29%)
AMD   98.77 (-3.61%)
CGC   5.77 (-2.04%)
MU   72.02 (-3.30%)
T   20.46 (-0.53%)
GE   75.65 (-0.98%)
F   13.02 (-3.77%)
DIS   105.81 (-2.60%)
AMC   13.47 (+4.42%)
PFE   50.58 (-1.48%)
PYPL   78.10 (-2.07%)
NFLX   182.77 (-4.09%)
QQQ   296.14 (-3.28%)
AAPL   143.54 (-3.82%)
MSFT   257.25 (-3.59%)
FB   196.07 (-3.23%)
GOOGL   2,263.13 (-2.85%)
AMZN   2,183.86 (-5.35%)
TSLA   731.31 (-3.98%)
NVDA   173.93 (-4.31%)
BABA   89.37 (-2.85%)
NIO   16.25 (-2.29%)
AMD   98.77 (-3.61%)
CGC   5.77 (-2.04%)
MU   72.02 (-3.30%)
T   20.46 (-0.53%)
GE   75.65 (-0.98%)
F   13.02 (-3.77%)
DIS   105.81 (-2.60%)
AMC   13.47 (+4.42%)
PFE   50.58 (-1.48%)
PYPL   78.10 (-2.07%)
NFLX   182.77 (-4.09%)
LON:VSN

Verseon (VSN) Share Forecast, Price & News

GBX 74
+1.50 (+2.07%)
(As of 03/15/2019)
Add
Compare
Today's Range
74
74
50-Day Range
74
74
52-Week Range
72.50
146.50
Volume
3,000 shs
Average Volume
75,334 shs
Market Capitalization
£112.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive VSN News and Ratings via Email

Sign-up to receive the latest news and ratings for Verseon and its competitors with MarketBeat's FREE daily newsletter.

About Verseon

Verseon Corporation, a pharmaceutical company, designs and develops novel therapeutics for various diseases in the United States. The company is involved in developing oral anticoagulants for various cardiovascular indications with novel pharmacology; kallikrein inhibitors for the treatment of diabetic macular edema and hereditary angioedema; and novel angiogenesis inhibitors for the treatment of solid tumors. Verseon Corporation was founded in 2002 and is headquartered in Fremont, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 11.19 per share
Book Value
GBX 21 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£112.24 million
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.85 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Verseon (LON:VSN) Frequently Asked Questions

Who are Verseon's key executives?
Verseon's management team includes the following people:
  • Mr. Adityo Prakash, CEO & Exec. Director
  • Ms. Eniko Fodor, Founder, CFO, COO, Company Sec. & Exec. Director (Age 51)
What is Verseon's stock symbol?

Verseon trades on the London Stock Exchange (LON) under the ticker symbol "VSN."

How do I buy shares of Verseon?

Shares of VSN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Verseon's stock price today?

One share of VSN stock can currently be purchased for approximately GBX 74.

How much money does Verseon make?

Verseon has a market capitalization of £112.24 million.

What is Verseon's official website?

The official website for Verseon is www.verseon.com.

How can I contact Verseon?

Verseon's mailing address is 48820 Kato Rd Ste 100B, FREMONT, CA 94538-7323, United States. The company can be reached via phone at +1-510-2259000.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.